
July 3, 2002
A new study conducted by researchers at the University of California at San Francisco says that women with heart disease who choose hormone replacement therapy (HRT) after menopause may increase their risk of developing gall bladder problems as well as severe blood clots. Millions of women each year undergo HRT to prevent osteoporosis, sleep disturbances and vaginal dryness. Recent studies have indicated that taking hormones such as estrogen and progestin also reduce a woman's risk of suffering a heart attack or stroke.
But data from the inquiry, known as the Heart and Estrogen/Progestin Replacement Study (HERS), reveals that a dangerous risk of gall bladder disease and blood clots in patients' legs and lungs exists for women undergoing HRT. According to the report, HRT also does not protect against cardiovascular disorders. The study, which appears in today's issue of the Journal of the American Medical Association, monitored 2,763 elderly women--using either a hormone or placebo--for four years.
-- Article Courtesy of InjuryBoard.com
.
Contents & Site Design © Injury Issues.com